{
    "organizations": [],
    "uuid": "a300447807109a148f8b7a074d358f3a62348ca7",
    "author": "",
    "url": "https://www.reuters.com/article/brief-tonix-pharmaceuticals-receives-ind/brief-tonix-pharmaceuticals-receives-ind-clearance-by-u-s-fda-for-tnx-102-sl-idUSFWN1S806X",
    "ord_in_thread": 0,
    "title": "BRIEF-Tonix Pharmaceuticals Receives IND Clearance By U.S. FDA For TNX-102 SL",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1, 2018 / 11:21 AM / Updated 13 minutes ago BRIEF-Tonix Pharmaceuticals Receives IND Clearance By U.S. FDA For TNX-102 SL Reuters Staff 1 Min Read\nMay 1 (Reuters) - Tonix Pharmaceuticals Holding Corp :\n* TONIX PHARMACEUTICALS RECEIVES IND CLEARANCE BY U.S. FDA FOR TNX-102 SL IN AGITATION IN ALZHEIMERâ€™S DISEASE Source text for Eikon: Further company coverage:",
    "published": "2018-05-01T14:21:00.000+03:00",
    "crawled": "2018-05-01T14:41:49.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "receives",
        "ind",
        "clearance",
        "fda",
        "sl",
        "reuters",
        "staff",
        "min",
        "read",
        "may",
        "reuters",
        "tonix",
        "pharmaceutical",
        "holding",
        "corp",
        "tonix",
        "pharmaceutical",
        "receives",
        "ind",
        "clearance",
        "fda",
        "sl",
        "agitation",
        "alzheimer",
        "disease",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}